A study on the clinical characteristics, risk factors and economic burden of serious adverse drug reactions in hospitalized patients
British Journal of Clinical Pharmacology · 2026
DOI: 10.1002/bcp.70683 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Yue Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Lu'an Hospital Affiliated to Anhui Medical University, Lu'an, China. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Hospitalization, Hospital Costs. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Lu'an science and technology plan project.
Abstract (Originalsprache)
Aim
Epidemiological knowledge regarding the occurrence of serious adverse drug reactions (sADRs) among hospitalized patients in China is limited. To enhance medication safety, an assessment of local epidemiology is essential.
Methods
A case–control study design was employed. Cases of sADRs in hospitalized patients during 2022–2024 were collected to form the case group. Patients without ADRs were matched 1:1 with patients who experienced sADRs using propensity score matching. The matched patients formed the control group. Univariate and multivariate logistic regression analyses were used to explore risk factors for sADRs. Differences in hospitalization costs were compared to clarify the economic burden of sADRs, and the potential cost savings achievable through the prevention of avoidable sADRs were calculated.
Results
A total of 588 cases were included, with 294 cases each in the case and control group. The incidence of sADRs was 0.09%. Of these sADRs, 39.1% were assessed as preventable. Nutritional risk (OR = 1.689; 95% CI: 1.128–2.529), inadequate therapeutic monitoring (OR = 6.175; 95% CI: 3.994–9.548) and poor adherence (OR = 2.439; 95% CI: 1.492–3.988) were identified as independent risk factors ( P < 0.05). The average hospitalization cost in the case group was ¥9411.50 ($1352.23) higher than that in the control group. The potential cost savings achievable through the prevention of sADRs were estimated at ¥1081889.57 ($155443.90).
Conclusion
The economic burden of sADRs among hospitalized patients is higher than previously recognized. To prevent sADRs in the hospital, close monitoring by physicians and strict adherence by patients is essential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Lu'an Hospital Affiliated to Anhui Medical University, Lu'an, China.
ORCID-Profile: Yue Chen
Förderung
- Lu'an science and technology plan project
Zitieren
APA
Chen, Y., Huang, M., Wu, L., Xia, Y., Zhang, J., & Wang, F. (2026). A study on the clinical characteristics, risk factors and economic burden of serious adverse drug reactions in hospitalized patients. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70683
Vancouver
Chen Y, Huang M, Wu L, Xia Y, Zhang J, Wang F. A study on the clinical characteristics, risk factors and economic burden of serious adverse drug reactions in hospitalized patients. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70683
BibTeX
@article{Chen2026,
author = {Chen, Yue and Huang, Mengmeng and Wu, Lei and Xia, Yimiao and Zhang, Jing and Wang, Facai},
title = {A study on the clinical characteristics, risk factors and economic burden of serious adverse drug reactions in hospitalized patients},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70683}
}
EUVIMED